Stock 300972 FUJIAN WANCHEN BIOTECHNOLOGY GROUP CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

All News Fujian Wanchen Biotechnology Group Co., Ltd.

Equities

300972

CNE100004KH1

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-05-22 pm EDT 		5-day change 1st Jan Change
26.63 CNY -2.17% Intraday chart for Fujian Wanchen Biotechnology Group Co., Ltd. -1.11% -29.06%
Apr. 26 Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 22 Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Certain A Shares of Fujian Wanchen Biotechnology Co., Ltd are subject to a Lock-Up Agreement Ending on 19-APR-2024.
CI
Fujian Wanchen Biotechnology Group Co., Ltd. announced that it has received CNY 200 million in funding
CI
Fujian Wanchen Biotechnology Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
CI
Fujian Wanchen Biotechnology Co., Ltd Announces Management Appointments
CI
Fujian Wanchen Biotechnology Co., Ltd has Changed its Name to Fujian Wanchen Biotechnology Group Co., Ltd
CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Fujian Wanchen Biotechnology Co., Ltd announced that it expects to receive CNY 200 million in funding
CI
Nanjing Wanpin Commercial Management Co., Ltd. announced that it expects to receive CNY 7 million in funding from Fujian Wanchen Biotechnology Co., Ltd, Huainan Shengyu Enterprise Management Co., Ltd, Huainan Huixiang Enterprise Management Co., Ltd., Xinghua Dewen Management Consulting Co., Ltd., Xinghua Geometry Management Consulting Co., Ltd., and other investors
CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Fujian Wanchen Biotechnology Co., Ltd Announces 2021 Final Profit Distribution Plan to Be Implemented (A Shares), Payment Date: 06 June 2022
CI
Fujian Wanchen Biotechnology Co., Ltd Announces Dividend for 2021
CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
Fujian Wanchen Biotechnology Co., Ltd Proposes Final Cash Dividend for 2021
CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Fujian Wanchen Biotechnology Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2021
CI
Fujian Wanchen Biotechnology : Edible Fungus Maker Wanchen Biotechnology to List Nearly 1.3% Stake Post IPO Lockup
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 300972 Stock
  4. News Fujian Wanchen Biotechnology Group Co., Ltd.